Skin
Glycopyrrolate (topical)
Anticholinergic Agent (topical)
Other names: Qbrexza
Wait
24 hours
after the first dose
The FAA's MedGuide lists glycopyrrolate (topical) (Qbrexza) as allowed, for hyperhidrosis, with a wait of 24 hours after the first dose and none after later doses or after the final dose, used as prescribed.
Track your medicationsMore detail: glycopyrrolate (topical)The rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 24 hours after the first dose: ground observation
Show the FAA's words: glycopyrrolate (topical)The official FAA wording: three passages, each with its document and dateOpen
Generic: glycopyrrolate (topical)
Brand Name: Qbrexza
Drug Class: Anticholinergic Agent (topical)
Underlying Condition: Hyperhidrosis
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.